Shawn Smith, PharmD

• PGY2 Ambulatory Care Pharmacy Residency, Virginia Commonwealth University School of Pharmacy, 2018-2019
• PGY1 Ambulatory Care Pharmacy Residency, University of California at San Diego Health, 2017-2018
• Doctor of Pharmacy, 2017, Loma Linda University
• Pre-Pharmacy Studies, Bloomsburg University of Pennsylvania

Dr. Smith’s current teaching responsibilities include coordination of the physical assessment portion of the curriculum. He also teaches cardiometabolic disease state management with a focus on diabetes mellitus, hypertension, dyslipidemia, heart failure, and smoking cessation.

Dr. Smith’s research and practice interests involve engaging in community partnerships to develop innovative practice models in underserved populations to improve access to primary healthcare services and medications.

• ‘Navigation Center & Recuperative Care in HPSA. CA DHCS – PATH CITED.

• ‘Recuperative Care Operational Support’ California Health Care Foundation.

• ‘Enhancing Clinical Pharmacy Services in the Underserved Population’ National Association of Free and Charitable Clinics

• ‘Improving Influenza & Hepatitis A Vaccination Rates in the Homeless Population’ Direct Relief – Pfizer Innovation Awards in Community Heath: Addressing Infectious Disease in Underserved Communities

• “Expanding Behavioral Health Services in the Homeless Population” City of Victorville – Community Development Block Grant, US Department of Housing and Urban Development.

• “Community Clinic Core Operating Support” California Wellness Foundation – Advancing Wellness

• “COVID-19 Test to Treat High Desert Initiative” California Department of Public Health

• “COVID-19 Prevention through Testing, Contact Tracing, Vaccinations, Community Engagement, and Education in Homeless Populations” RADx® Underserved Populations (RADx-UP).

• “Chronic Disease Management for Uninsured High Desert Residents” Kaiser Foundation Hospitals Fontana.

• “Community Routes: Access to Mental Health Care” National Association of Free and Charitable Clinics/Teva Pharmaceuticals/Direct Relief

• "COVID-19 Prevention and Treatment in the Homeless Population” City of Victorville. Community Development Block Grant.

• "Improving Access to Behavioral Health Services in Homeless Shelters” National Association of Free and Charitable Clinics & CVS Health Foundation.

• "Equitable Access to COVID-19 Testing” National Association of Free and Charitable Clinics & Center for Disaster Philanthropy.

• "Chronic Disease Management for Uninsured High Desert Residents” Kaiser Foundation Hospitals Fontana.

• City of Victorville Community Development Block Grant: CARES ACT

• High Desert Community Foundation COVID-19 Relief Fund

• Center for Disaster Philanthropy COVID-19 Relief

• Pollination Project COVID-19 Relief

• Inland Empire Community Foundation COVID-19 Relief

• United Way COVID-19 Relief Fund

• California Pharmacist Association Excellence in Innovation Award, 2023

• WesternU COP Preceptor of the Year Award, 2023

• McKeen Cattell Memorial Award, Journal of Clinical Pharmacology, 2019
• President’s Award, Loma Linda University School of Pharmacy, 2017

• National Association of Free and Charitable Clinics (NAFC)

• California Association of Free and Charitable Clinics (CAFCC)

• American Academy of Colleges of Pharmacy (AACP)

• American Association of Diabetes Educators (AADE)

• American College of Cardiology (ACC)

• American College of Clinical Pharmacy (ACCP)

• The Rho Chi Society: Gamma Rho Chapter

Andraos, J, Smith, SR, Tran, A. et al. Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes. J Diabetes Metab Disord (2024). https://doi.org/10.1007/s40200-024-01406-6

Smith SR, Banuelos L, Trujillo N, et al. Adverse childhood experiences among California student pharmacists. Ment Health Clin. 2024;14(1):1-9. https://doi.org/10.9740/mhc.2024.02.001

Andraos, J, Muhar, H, Smith, SR. Beyond glycemia: Comparing tirzepatide to GLP-1 analogues. Rev Endocr Metab Disord (2023). https://doi.org/10.1007/s11154-023-09825-1.

Nguyen DD, Lu L, Smith SR. Evidence-Based Appraisal of the DAPA-CKD Trial. Journal of Contemporary Pharmacy Practice (2022) 69 (1): 19–24. https://doi.org/10.37901/jcphp21-00011

Smith SR, Ruiz CW, Ali S, et al. A pharmacist-led collaborative care model for cardiometabolic risk reduction: a case study. ADCES in Practice. 2021;9(3):16-23. https://doi.org/10.1177/2633559X21994855

Aranda JP, Smith SR, Nguyen HN, Jap C, Gogineni HP. Virtual physical assessment training during the COVID-19 pandemic - student pharmacists’ performance & perceptions. PharmacyEducation (2020) 20(2) 165 – 173. https://doi.org/10.46542/pe.2020.202.165173

Smith SR, Schwartzman E, Hata M. Team-based hypertension management in outpatient settings. JCOM. 2020;27(3).

Martino JG, Smith SR, Rafie S, Rafie S, Marienfeld C. Physician and Pharmacist: Attitudes, Facilitators, and Barriers to Prescribing Naloxone for Home Rescue. Am J Addict. 2019; https://doi.org/10.1111/ajad.12982

Sisson EM, Kim CJ, Smith SR. AADE Quick Guide to Medications, 9th Edition. Chicago: American Association of Diabetes Educators; 2019. ISBN 978-1-881876-52-6

Dixon DL, Pamulapati LG, Bucheit JD, Sisson, EM, Smith SR, Kim CJ, Wohlford GF, Pozen J. Recent Updates on the Use of PCSK9 Inhibitors in Patients with Atherosclerotic Cardiovascular Disease. Curr Atheroscler Rep. 2019;21(5):16.
https://doi.org/10.1007/s11883-019-0778-6

Hill L, Smith SR, Karris MY. Profile of bictegravir/emtricitabine/tenofovir alafenamide fixed dose combination and its potential in the treatment of HIV-1 infection: evidence to date. HIV AIDS (Auckl). 2018;10:203-213.
https://doi.org/10.2147/HIV.S145529

Truong J, Smith SR, Veillette JJ, Forland SC. Individualized pharmacokinetic dosing of vancomycin reduces time to therapeutic trough concentrations in critically ill patients. J Clin Pharmacol. 2018;58(9):1123-1130.
https://doi.org/10.1002/jcph.1273